about
Heterogeneous genetic alterations in ovarian mucinous tumors: application and usefulness of laser capture microdissection.Case of clear cell ependymoma of medulla oblongata: clinicopathological and immunohistochemical study with literature review.Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas.Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions.PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells.Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma.Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma.Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia.Diffuse leptomeningeal glioneuronal tumor (DLGNT) mimicking Whipple's disease: a case report and literature review.Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.Sellar Atypical Teratoid/Rhabdoid Tumor (AT/RT): A Clinicopathologically and Genetically Distinct Variant of AT/RT.Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papillomavirus infection.Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone.Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung.Proton MRS detection of high lipid levels and low ADC is characteristics of germinoma.Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement.Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation.Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging.Role for loss of nuclear PTEN in a harbinger of brain metastases.MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma.Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia.MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.Myxopapillary ependymoma with anaplastic features.Trigeminal neuropathy from perineural spread of an amyloidoma detected by blink reflex and thin-slice magnetic resonance imagingMUC21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinomaConcurrent Schwannoma and Meningioma Arising in the Same Spinal Level: A Report of Two CasesmiR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in MesotheliomaImproved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CTIdiopathic granulomatous meningoencephalitis presenting as an intracranial tumorImmunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomasMeningioangiomatosis occurring in a young male without neurofibromatosis: with special reference to its histogenesis and loss of heterozygosity in the NF2 gene regionImmunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinomaDifferential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistryEsophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation
P50
Q30771289-9AF32D05-1D4C-4EA8-A59F-27E9FB27E25EQ30788683-B7632C4F-85F6-4294-9D61-3AF4D59722A5Q36329690-025FF991-68F3-4E32-9BB3-B906F04D02BCQ37372717-86094148-0B7E-429B-84F8-C7774770B853Q37460230-B09E4C0B-FD16-4E92-B40A-D14FE259E4ADQ38716459-0BB61BC6-2A5E-4654-9E6A-F9919D1E6627Q38732461-8F8DB5C9-0D25-4ACB-9FFF-5FBBBE2B7DBCQ38798870-DE82B6C4-874E-4861-9535-F5CA0A60CE67Q38806201-D31A290C-2221-45FF-8212-C830960D0CA5Q39223549-52865D42-C087-4AFA-943D-0A5456D9C9FEQ39479172-BF9D2253-666D-403A-9B40-6BD7C0EB2C39Q40276082-62A53718-5FA8-4F97-9F9B-AFC3F8DA5D3AQ42519326-17623249-6B07-4C02-9B24-350785000901Q46258846-913CEBB5-1401-40D8-A1AB-4927E81DF38CQ46891964-53237FE9-0903-410A-B085-190BB337DC9AQ47365828-EDC97666-9059-4009-A98B-BCB538A044B5Q47560451-F73AB723-AA14-4809-9456-B0D2FA8E32A0Q47616531-E729CBB3-386C-4C36-BBED-A1EFF4041DDAQ47791754-E93EACE2-9DA4-4766-ADD4-E97AEF1837E5Q47811365-0A6B209C-54DE-4B00-85E3-CF22A0B160C9Q48003738-9BD9A0BF-C333-4BD6-9A77-40D5F29D2503Q48205293-78FBE196-F2F6-49ED-A281-ADC5DC1F06A4Q48276348-1FD6FB02-77FB-4401-B90D-2525477B0BCEQ48293082-02402387-5852-4033-AD99-744A8FCB89F5Q48556264-04FCCA80-17C1-42CA-AAEE-8536D8F715C1Q50071611-976627AA-878A-403A-AFF1-13395474BDF3Q50202471-6DAD356A-8764-4881-B7EE-0E9A4EBE63C0Q53709257-4A20EE02-D6FD-4194-8E08-59C053B6E096Q55472553-F3EB37F3-AC59-4FAD-9AF5-EEE363241980Q57125841-D963A2A2-B188-4E3C-9C3C-ADEC848C69A2Q57453310-6D653277-4631-4316-A954-109DB42D83C4Q57493535-84E25476-0EA9-43D3-A590-8ED2F2382BBCQ58580685-4E507602-C209-4ABA-A99D-87BEA733A177Q58789024-5D4F167B-5BE5-4B8C-AE0A-2A938B27D74DQ73348611-F19E33D5-758F-4C0D-B1F2-632A6A68E033Q74538939-CBEBCF78-0918-4839-B735-2D3844A5B97CQ77388250-1E25B28F-EC37-42D0-949D-04352E326B95Q79815377-5E0D56A4-0338-45C7-974C-C93CA73C54C4Q80501530-0F3B255D-BA20-443F-92E6-36CCEBC3F0F6Q80857695-A88D754A-9A70-4092-A7FE-E56C3B7AD44F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vishwa Jeet Amatya
@ast
Vishwa Jeet Amatya
@en
Vishwa Jeet Amatya
@es
Vishwa Jeet Amatya
@nl
type
label
Vishwa Jeet Amatya
@ast
Vishwa Jeet Amatya
@en
Vishwa Jeet Amatya
@es
Vishwa Jeet Amatya
@nl
prefLabel
Vishwa Jeet Amatya
@ast
Vishwa Jeet Amatya
@en
Vishwa Jeet Amatya
@es
Vishwa Jeet Amatya
@nl
P106
P1153
6602691906
P31
P496
0000-0002-4986-2109